approved EB-2 (NIW)

Graduate Student

Biomedical Engineering · China · 2023-12-14

Processing Time
7 days
Decision Date
2023-12-14
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on using microfluidics, organ-on-chip, and 3D bioprinting techniques to develop novel tissue engineering models for the lymphatic and ophthalmic systems. This work aims to identify therapeutic targets for diseases and address the growing demand for tissue engineering solutions and the prevalence of lymphatic and ophthalmic diseases.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses the growing demand for tissue engineering and the prevalence of lymphatic and ophthalmic diseases.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a strong record of publications in top journals, 33 citations, and filed patents demonstrating peer recognition.

3 Balance of Interests Met

The petitioner's subject-matter expertise and the urgency of medical technology advancement make a waiver of the labor certification beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.Sc. degree, 5 peer-reviewed journal articles, 33 citations, and 2 filed patents. Additionally, the petitioner had completed 3 peer reviews and received funding from the National Natural Science Foundation of China, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Grants
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Others

Nanotechnology · China

WeGreened EB-2 (NIW) approved
California 30 days 2025-02-26
The petitioner proposes to continue research on applying and advancing cutting-edge 3D printing technologies to develop in vitro models of diseases and engineered designs for medical and environmental applications. Her work specifically focuses on 3D bioprinting methods, photosynthetic living biomaterials for pollutant degradation, artificial coral structures, and succulent-based microneedles for sustained drug release.

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
New York 12 days 2025-04-01
The petitioner proposes to continue developing advanced microfluidic systems that integrate precision micro-fabrication with high-resolution imaging to replicate complex human body microenvironments. This work focuses on creating scalable platforms to observe cell behavior in realistic conditions, specifically targeting the study of cancer, neurodegenerative disorders, and antibiotic-resistant infections.

Research Scientist

Biotechnology · Greece

WeGreened EB-2 (NIW) approved
Washington 117 days 2023-02-01
The petitioner proposes to design technological infrastructure for new, cost-effective, industry-grade tools that interface with and house human tissue. This work focuses on advancing the development of novel disease treatments and vaccines by modeling human tissues and their response to vaccination agents.

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
Arizona 62 days 2025-04-16
The petitioner proposes to engineer novel bacterial systems by integrating synthetic biology and microfluidics to create engineered living systems. This work aims to develop self-healing materials and precision drug delivery platforms for biomedical, biomanufacturing, and environmental applications. The research focuses on pioneering microbial innovations to advance the U.S. bioengineering sector.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-12-14.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 7 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist